Drugs / Therapeutics
· 07B093 - Esmolol Reduces Risks Following Heart Surgery
· 05B105 - Identification of drugs for efficacy to treat stroke at delayed timepoints
· 05A064 - Drug delivery by carbon nanotube-chitosan nanocomplexes
· 05A055 - A method of nanoparticle-mediated gene transfer
· 05A046 - Novel method of treatment for stroke using sigma receptor agonists
· 05A040 - Non-invasive radio-frequency controlled transdermal drug delivery system
· 05A030 - A method of transdermal drug delivery using hyaluronic acid nanoparticles
· 04A009 - Respirable nanoparticles for lung cancer
· 03B110 - STAT inhibitors for treatment of RSV infection
· 03B082 - Modulation of microglia inflammation by nicotinic medications - therapeutics for neuro-inflammation (neurodegenerative diseases)
· 03B063 - Cholinergic modulation of microglial activation by alpha7 nicotinic receptors (neurodegenerative diseases)
· 03B057 - Vigilant stem cell®
· 03A044 - Vigilant stem cell beacon®
· 03A012 - Treating dengue virus infection using genetically modified antivirals
· 03A009 - An E2F1 RNA inhibitor to prevent apoptosis (stroke
· 02B086 – Novel Anti-Cancer Vaccine: Inhibition of Tumor Stat3 Expression
· 02A024 - Protein kinase-C as a target for the treatment of respiratory syncytial virus
· 02A018 - A method of treating allergic disease and asthma by recombinant adenovirus mediated IFN-gamma gene transfer
· 01B052 - Intranasal chitosan-DNA nanospheres protect against acute respiratory syncytial viral infection
· 01A032 - N-Thiolated β-lactams for use in anti anti-cancer therapy
· 01A002 - Novel vasodilating compounds from grape extracts
· 00B053 - SHIP: A new protein target for allogeneic bone marrow transplants
· 00A004 - MPCs: A new effective treatment for transplantation
· 99B058 - N-Thiolated beta-lactam compounds
· 98B047 - STAT3: An attractive protein target for prevention and treatment of cancer
Main menu 8
